Clinical Research Directory
Browse clinical research sites, groups, and studies.
ESCUDDO Long Term Follow Up
Sponsor: National Cancer Institute (NCI)
Summary
This phase IV trial evaluates the long term protection provided by either one or two doses of the 9v human papillomavirus (HPV) vaccine for participants who were part of the ESCUDDO study.
Official title: A Scientific Evaluation of One or Two Doses of a Vaccine Against Human Papillomavirus: Long Term Follow Up of Gardasil9 Recipients in the ESCUDDO Study ("Estudio de Comparación de Una y Dos Dosis de Vacunas Contra el Virus de Papiloma Humano (VPH)")
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
13700
Start Date
2026-08-11
Completion Date
2031-01-15
Last Updated
2026-09-22
Healthy Volunteers
Yes
Interventions
Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed
Given IM in ESCUDDO (NCT03180034)
Recombinant Human Papillomavirus Nonavalent Vaccine
Given intramuscularly (IM) in ESCUDDO (NCT03180034)
Locations (1)
Agencia Costarricense de Investigaciones Biomédicas (ACIB)
Liberia, Guanacaste Province, Costa Rica